What they were paid
Janux Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $43,750 | $95,475 | $231,241 | $0 | $370,466 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Janux Therapeutics, Inc. DEF 14A filed April 28, 2026, accession 0001193125-26-187095, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Janux Therapeutics pays directors a $40,000 cash retainer and $326,716 in equity.
The rest of the Janux Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Alana McNulty | Independent Director | $379,841 |
| David Campbell, Ph.D | Director | $0 |
| Eric Dobmeier | Independent Director | $376,091 |
| Jake Simson, Ph.D | Independent Director | $381,591 |
| Natasha Hernday | Independent Director | $374,216 |
| Ron Barrett, Ph.D | Chair of the Board | $420,779 |
| Vickie Capps | Independent Director | $389,216 |
| Winston Kung | Independent Director | $379,841 |
The full Janux Therapeutics compensation record
free company briefThis page is one director within Janux Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat